Published in J Virol on January 23, 2008
Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev (2009) 2.75
Feeling manipulated: cytomegalovirus immune manipulation. Virol J (2009) 1.19
Human cytomegalovirus Fcγ binding proteins gp34 and gp68 antagonize Fcγ receptors I, II and III. PLoS Pathog (2014) 1.00
Recombinant human cytomegalovirus (HCMV) RL13 binds human immunoglobulin G Fc. PLoS One (2012) 0.92
CMV-encoded Fcγ receptors: modulators at the interface of innate and adaptive immunity. Semin Immunopathol (2014) 0.84
The decoy Fcγ receptor encoded by the cytomegalovirus UL119-UL118 gene has differential affinity to IgG proteins expressing different GM allotypes. Hum Immunol (2015) 0.82
Optimal replication of human cytomegalovirus correlates with endocytosis of glycoprotein gpUL132. J Virol (2010) 0.77
Exploitation of herpesviral transactivation allows quantitative reporter gene-based assessment of virus entry and neutralization. PLoS One (2011) 0.77
Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick Getaway. Microbiol Mol Biol Rev (2016) 0.76
Characterization of Antibody Bipolar Bridging Mediated by the Human Cytomegalovirus Fc Receptor gp68. J Virol (2016) 0.75
Highly individual patterns of virus-immune IgG effector responses in humans. Med Microbiol Immunol (2016) 0.75
The Fc Domain of Immunoglobulin Is Sufficient to Bridge NK Cells with Virally Infected Cells. Immunity (2017) 0.75
Interaction of Immunoglobulin with Cytomegalovirus-Infected Cells. Viral Immunol (2017) 0.75
Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. Biochemistry (1981) 6.13
Prediction, conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sites. Glycobiology (2004) 6.13
Membrane proteins specified by herpes simplex viruses. V. Identification of an Fc-binding glycoprotein. J Virol (1979) 5.52
High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R. J Biol Chem (2000) 5.18
Viral strategies of immune evasion. Science (1998) 4.48
Convergent solutions to binding at a protein-protein interface. Science (2000) 4.47
Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI. J Virol (1988) 4.32
The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex. Nature (2000) 3.53
Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells. J Virol (1994) 3.39
Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J Mol Biol (2003) 3.25
The IgG receptor induced by herpes simplex virus: studies using radioiodinated IgG. J Gen Virol (1974) 3.17
An IgG-Fc receptor induced in cytomegalovirus-infected human fibroblasts. J Immunol (1976) 3.14
An analysis of the in vitro and in vivo phenotypes of mutants of herpes simplex virus type 1 lacking glycoproteins gG, gE, gI or the putative gJ. J Gen Virol (1994) 2.92
Immune evasion by cytomegalovirus--survival strategies of a highly adapted opportunist. Trends Microbiol (1998) 2.75
Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding. Mol Cell (2001) 2.67
Biological significance of carbohydrate chains on monoclonal antibodies. Proc Natl Acad Sci U S A (1983) 2.33
The structure of a human type III Fcgamma receptor in complex with Fc. J Biol Chem (2001) 2.33
Demonstration of immunoglobulin G receptors induced by human cytomegalovirus. J Clin Microbiol (1975) 2.21
Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors. Methods Enzymol (1998) 2.14
The development by cytomegalovirus-infected cells of binding affinity for normal human immunoglobulin. J Immunol (1976) 2.12
A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G. J Virol (1989) 2.08
Isolation and expression of functional high-affinity Fc receptor complementary DNAs. Science (1989) 2.06
Appearance of IgG (Fc) receptor(s) on cultured human fibroblasts infected with human cytomegalovirus. J Immunol (1976) 2.05
Crystal structure of the HSV-1 Fc receptor bound to Fc reveals a mechanism for antibody bipolar bridging. PLoS Biol (2006) 1.99
Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J Virol (2002) 1.92
Crystal structure of the C2 fragment of streptococcal protein G in complex with the Fc domain of human IgG. Structure (1995) 1.86
Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI. J Virol (1992) 1.81
Fc receptors and their interactions with immunoglobulins. Annu Rev Cell Dev Biol (1996) 1.79
Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity. J Virol (1991) 1.73
Interaction sites on human IgG-Fc for FcgammaR: current models. Immunol Lett (2002) 1.62
In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor. J Virol (1998) 1.59
Glycoform-dependent conformational alteration of the Fc region of human immunoglobulin G1 as revealed by NMR spectroscopy. Biochim Biophys Acta (2005) 1.56
Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction. Nat Struct Biol (1997) 1.53
Virus attenuation after deletion of the cytomegalovirus Fc receptor gene is not due to antibody control. J Virol (1998) 1.44
The characterization of IgG receptor induced by human cytomegalovirus. Proc Soc Exp Biol Med (1977) 1.33
Characterization of the 2:1 complex between the class I MHC-related Fc receptor and its Fc ligand in solution. Biochemistry (1999) 1.31
The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. J Exp Med (2006) 1.27
Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor. J Virol (1994) 1.24
Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing Fc gamma RI and/or Fc gamma RII receptors. Biochem J (1989) 1.22
Construction and isolation of recombinant MVA. Methods Mol Biol (2004) 1.19
pH dependence and stoichiometry of binding to the Fc region of IgG by the herpes simplex virus Fc receptor gE-gI. J Biol Chem (2004) 1.18
Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein. J Virol (2001) 1.15
Characterization of the interaction between the herpes simplex virus type I Fc receptor and immunoglobulin G. J Biol Chem (1999) 1.14
Binding of human and animal immunoglobulins to the IgG Fc receptor induced by human cytomegalovirus. J Gen Virol (2001) 1.06
Antibody-induced and cytoskeleton-mediated redistribution and shedding of viral glycoproteins, expressed on pseudorabies virus-infected cells. J Virol (1997) 1.05
Viral interference with B7-1 costimulation: a new role for murine cytomegalovirus fc receptor-1. J Immunol (2006) 1.04
Consequences of human cytomegalovirus mimicry. Hum Immunol (2004) 0.95
Crystal structure of the extracellular domain of a human Fc gamma RIII. Immunity (2000) 0.94
Induction of surface IgG receptors in cytomegalovirus-infected human fibroblasts. Eur J Biochem (1984) 0.94
Human immunoglobulin class and subclass specificity of Fc receptors induced by herpes simplex virus type 1. J Virol (1984) 0.93
Direct evidence for antibody bipolar bridging on herpes simplex virus-infected cells. Immunology (1992) 0.93
X-ray crystallographic studies of IgG-Fc gamma receptor interactions. Biochem Soc Trans (2002) 0.88
Immune evasion by herpes simplex virus type 1, strategies for virus survival. Trans Am Clin Climatol Assoc (2003) 0.87
Herpes simplex type 1-induced Fc receptor binds to the Cgamma2-Cgamma3 interface region of IgG in the area that binds staphylococcal protein A. Immunology (1989) 0.85
Binding site and subclass specificity of the herpes simplex virus type 1-induced Fc receptor. Immunology (1985) 0.85
Herpesviral Fcgamma receptors: culprits attenuating antiviral IgG? Int Immunopharmacol (2004) 0.84
Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science (2011) 9.00
Hot L1s account for the bulk of retrotransposition in the human population. Proc Natl Acad Sci U S A (2003) 6.16
Host immune system gene targeting by a viral miRNA. Science (2007) 5.10
Increasing the potency and breadth of an HIV antibody by using structure-based rational design. Science (2011) 4.30
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies. Proc Natl Acad Sci U S A (2012) 3.33
Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization. Cell (2013) 3.04
Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J Immunol (2003) 3.02
Decoding human cytomegalovirus. Science (2012) 2.98
Phenotypic properties of transmitted founder HIV-1. Proc Natl Acad Sci U S A (2013) 2.75
MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat Immunol (2002) 2.66
Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus. Nat Immunol (2011) 2.51
Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood (2005) 2.40
The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metab (2008) 2.36
Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. J Gen Virol (2008) 2.35
Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120. Proc Natl Acad Sci U S A (2012) 2.13
A novel human polyomavirus closely related to the african green monkey-derived lymphotropic polyomavirus. J Virol (2011) 2.03
Crystal structure of the HSV-1 Fc receptor bound to Fc reveals a mechanism for antibody bipolar bridging. PLoS Biol (2006) 1.99
Few and far between: how HIV may be evading antibody avidity. PLoS Pathog (2010) 1.94
Retracted IgG transcytosis and recycling by FcRn expressed in MDCK cells reveals ligand-induced redistribution. EMBO J (2002) 1.94
Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J Virol (2002) 1.92
The chicken yolk sac IgY receptor, a functional equivalent of the mammalian MHC-related Fc receptor, is a phospholipase A2 receptor homolog. Immunity (2004) 1.88
Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat Immunol (2003) 1.86
HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice. Proc Natl Acad Sci U S A (2013) 1.85
Interaction of hemojuvelin with neogenin results in iron accumulation in human embryonic kidney 293 cells. J Biol Chem (2005) 1.78
Structure of a clade C HIV-1 gp120 bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivity. Nat Struct Mol Biol (2010) 1.77
Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10. Proc Natl Acad Sci U S A (2009) 1.74
Extension of Drosophila melanogaster life span with a GPCR peptide inhibitor. Nat Chem Biol (2007) 1.70
A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses. J Exp Med (2005) 1.68
Case definition for progressive multifocal leukoencephalopathy following treatment with monoclonal antibodies. J Neurol Neurosurg Psychiatry (2012) 1.66
Early clinical experiences with the new influenza A (H1N1/09). Dtsch Arztebl Int (2009) 1.65
Role of interleukin 16 in multiple myeloma. J Natl Cancer Inst (2012) 1.62
A linear lattice model for polyglutamine in CAG-expansion diseases. Proc Natl Acad Sci U S A (2002) 1.62
NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J Exp Med (2005) 1.60
Hepatitis C virus mutation affects proteasomal epitope processing. J Clin Invest (2004) 1.58
Restricting HIV-1 pathways for escape using rationally designed anti-HIV-1 antibodies. J Exp Med (2013) 1.56
Expansion of protective CD8+ T-cell responses driven by recombinant cytomegaloviruses. J Virol (2004) 1.55
Crystal structure of a polymeric immunoglobulin binding fragment of the human polymeric immunoglobulin receptor. Structure (2004) 1.54
Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc. Nature (2003) 1.53
Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase. Proc Natl Acad Sci U S A (2005) 1.49
Solution structure of choline binding protein A, the major adhesin of Streptococcus pneumoniae. EMBO J (2004) 1.47
NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood (2010) 1.38
Computational analysis of anti-HIV-1 antibody neutralization panel data to identify potential functional epitope residues. Proc Natl Acad Sci U S A (2013) 1.37
Ligand valency affects transcytosis, recycling and intracellular trafficking mediated by the neonatal Fc receptor. Traffic (2006) 1.36
The CD8 T-cell response against murine gammaherpesvirus 68 is directed toward a broad repertoire of epitopes from both early and late antigens. J Virol (2008) 1.35
The structure of a polyQ-anti-polyQ complex reveals binding according to a linear lattice model. Nat Struct Mol Biol (2007) 1.29
The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. J Exp Med (2006) 1.27
Rapid replacement of endemic measles virus genotypes. J Gen Virol (2002) 1.25
A mouse model for HIV-1 entry. Proc Natl Acad Sci U S A (2012) 1.23
Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. J Virol (2005) 1.21
Neogenin interacts with hemojuvelin through its two membrane-proximal fibronectin type III domains. Biochemistry (2008) 1.20
Human cytomegalovirus interferes with signal transducer and activator of transcription (STAT) 2 protein stability and tyrosine phosphorylation. J Gen Virol (2008) 1.19
pH dependence and stoichiometry of binding to the Fc region of IgG by the herpes simplex virus Fc receptor gE-gI. J Biol Chem (2004) 1.18
The cytomegaloviral protein pUL138 acts as potentiator of tumor necrosis factor (TNF) receptor 1 surface density to enhance ULb'-encoded modulation of TNF-α signaling. J Virol (2011) 1.17
IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion. J Clin Invest (2014) 1.17
Construction of a fully retargeted herpes simplex virus 1 recombinant capable of entering cells solely via human epidermal growth factor receptor 2. J Virol (2008) 1.16
Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptor. Proc Natl Acad Sci U S A (2008) 1.13
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption. Nature (2016) 1.13
Design and expression of a dimeric form of human immunodeficiency virus type 1 antibody 2G12 with increased neutralization potency. J Virol (2008) 1.11
Bivalent binding of IgA1 to FcalphaRI suggests a mechanism for cytokine activation of IgA phagocytosis. J Mol Biol (2003) 1.11
Laboratory investigations are indispensable to monitor the progress of measles elimination--results of the German Measles Sentinel 1999-2003. J Clin Virol (2004) 1.11
Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin. PLoS Pathog (2011) 1.11
Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia. Am J Hematol (2011) 1.11
Evaluation of CD4-CD4i antibody architectures yields potent, broadly cross-reactive anti-human immunodeficiency virus reagents. J Virol (2010) 1.08
Structure of a pheromone receptor-associated MHC molecule with an open and empty groove. PLoS Biol (2005) 1.07
Single-chain Fv-based anti-HIV proteins: potential and limitations. J Virol (2011) 1.07
Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies? J Gen Virol (2005) 1.06
Neogenin-mediated hemojuvelin shedding occurs after hemojuvelin traffics to the plasma membrane. J Biol Chem (2008) 1.06
Cryo-electron tomography of homophilic adhesion mediated by the neural cell adhesion molecule L1. Structure (2009) 1.05
Heterotypic interactions between transferrin receptor and transferrin receptor 2. Blood (2002) 1.04
FcRn mediates elongated serum half-life of human IgG in cattle. Int Immunol (2006) 1.03
Crystal structure of LIR-2 (ILT4) at 1.8 A: differences from LIR-1 (ILT2) in regions implicated in the binding of the Human Cytomegalovirus class I MHC homolog UL18. BMC Struct Biol (2002) 1.03
The dynamics of mouse cytomegalovirus-specific CD4 T cell responses during acute and latent infection. J Immunol (2008) 1.03
Absence of cross-presenting cells in the salivary gland and viral immune evasion confine cytomegalovirus immune control to effector CD4 T cells. PLoS Pathog (2011) 1.00
A cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction. J Virol (2004) 0.99
The chicken yolk sac IgY receptor, a mammalian mannose receptor family member, transcytoses IgY across polarized epithelial cells. Mol Biol Cell (2008) 0.98
Dimeric 2G12 as a potent protection against HIV-1. PLoS Pathog (2010) 0.98
CD34+ progenitor cells mobilized by natalizumab are not a relevant reservoir for JC virus. Mult Scler (2010) 0.98
Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibody. Proc Natl Acad Sci U S A (2013) 0.97
A gammaherpesvirus ubiquitin-specific protease is involved in the establishment of murine gammaherpesvirus 68 infection. J Virol (2009) 0.97
Crystal structure of a secreted insect ferritin reveals a symmetrical arrangement of heavy and light chains. J Mol Biol (2005) 0.97
Electron tomography of late stages of FcRn-mediated antibody transcytosis in neonatal rat small intestine. Mol Biol Cell (2012) 0.96
A freeze substitution fixation-based gold enlarging technique for EM studies of endocytosed Nanogold-labeled molecules. J Struct Biol (2007) 0.96
Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor-induced signal transduction by cleavage of the T-cell protein tyrosine phosphatase. Hepatology (2009) 0.95
c-Src is required for complex formation between the hepatitis C virus-encoded proteins NS5A and NS5B: a prerequisite for replication. Hepatology (2011) 0.94
"Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells. J Immunol (2013) 0.92
Vaccination against infection in patients with multiple sclerosis. Nat Rev Neurol (2012) 0.91
Identification of DNA-damage DNA-binding protein 1 as a conditional essential factor for cytomegalovirus replication in interferon-γ-stimulated cells. PLoS Pathog (2011) 0.90
Gamma interferon-induced interferon regulatory factor 1-dependent antiviral response inhibits vaccinia virus replication in mouse but not human fibroblasts. J Virol (2009) 0.90
Crystal structure of TNFalpha complexed with a poxvirus MHC-related TNF binding protein. Nat Struct Mol Biol (2009) 0.90
Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets—but how many arrows in the quiver? Cell Mol Immunol (2014) 0.90
Loop nucleotides control primary and mature miRNA function in target recognition and repression. RNA Biol (2011) 0.90
Inhibition of mouse TAP by immune evasion molecules encoded by non-murine herpesviruses. Mol Immunol (2011) 0.89
A dimeric form of the HIV-1 antibody 2G12 elicits potent antibody-dependent cellular cytotoxicity. AIDS (2010) 0.89
The role of multiplex PCR in respiratory tract infections in children. Dtsch Arztebl Int (2014) 0.87
Physical and functional interactions of the cytomegalovirus US6 glycoprotein with the transporter associated with antigen processing. J Biol Chem (2005) 0.87
The crucial role of molecular diagnostics. Dtsch Arztebl Int (2014) 0.87
Mouse cytomegalovirus inhibits beta interferon (IFN-beta) gene expression and controls activation pathways of the IFN-beta enhanceosome. J Gen Virol (2008) 0.86
Human cytomegalovirus disrupts the major histocompatibility complex class I peptide-loading complex and inhibits tapasin gene transcription. J Virol (2011) 0.86